The liberation of arachidonic acid (AA) was investigated in platelet membranes prelabelled with [3H]AA. In rat platelet membranes, Ca2l at concentrations over several hundred nanomolar induced [3H]AA release, with a concurrent decrease in 3H radioactivity of phosphatidylethanolamine and phosphatidylcholine. Some 4-6o of total radioactivity incorporated into platelet membrane lipids was released at 1-10 ,tM-Ca2", which is nearly equivalent to that attained in agonist-stimulated platelets. 
INTRODUCTION
In response to certain physiological or pharmacological stimuli, platelets release arachidonic acid (AA), which is then converted into biologicaly active prostaglandins, thromboxanes and 12-HETE. Because the intracellular concentration of free AA is low, the liberation of AA from its sn-2 linkage in membrane phospholipids is a necessary first step toward the production of thromboxane A2 and other eicosanoids [1] . Two major pathways have been proposed for AA liberation; direct deacylation of phospholipids by phospholipase A2 [2] , and sequential action of phosphoinositide-specific phospholipase C followed by diacylglycerol (DG) lipase [3] . The former is thought to play a greater role for AA release in stimulated platelets [4] [5] [6] [7] [8] .
Phospholipase A2 has been purified from the membrane as well as the cytosolic fraction of platelets [9] [10] [11] [12] [13] [14] [15] . Although most investigators have reported that maximal activation of the enzyme system in vitro requires millimolar Ca21 concentrations, some recent studies have described its activation at micromolar Ca2+ [13] [14] [15] . As for the regulatory mechanism(s) of phospholipase A2 in receptor-stimulated platelets, several possibilities have been proposed: limited proteolysis [16] , lipocortin [17] , membrane physical state (substrate accessibility) [18] and Na+/H+ exchange [19, 20] . However, the precise mechanism underlying the receptor-mediated phospholipase A2 activation is still obscure. Our recent observations have suggested evidence for implication of GTPbinding protein in phospholipase A2 activation in permeabilized human platelets [21, 22] .
The present study was designed to examine phospholipase A2 activation in [3H]AA-prelabelled platelet membrane preparations. It was found that the activity was critically dependent on the free Ca2+ concentration in rat platelet membranes, but not in human platelet membranes. In rat platelet membranes, phospholipase A2 was effectively activated by Ca2" at 0.5-10 ,aM, which corresponded to cytoplasmic Ca2" concentrations observed in stimulated platelets.
EXPERIMENTAL
Preparation of I3HIAA-labelled platelets Human blood was drawn from healthy young volunteers, who had no medication for at least 2 weeks [22] .
Rat blood was removed from the abdominal aorta of overnight-fasted male Wistar rats, into plastic syringes with 1 vol. of anticoagulant (acid-citrate-dextrose) [22] for 6 vol. of blood. Platelet-rich plasma was obtained after centrifugation at 200 g for 10 min. The platelet pellet, obtained after centrifugation (1000 g for 10 min) of the platelet-rich plasma, was washed twice at room temperature in 25 ml of a modified Tyrode-Hepes buffer (134 mM-NaCl, 12 mM-NaHCO3, 2.9 mM-KCl, 0.36 mMNaH2PO4, 1 mM-MgCl2, 5.9 mM-dextrose, 10 mM-Hepes, pH 7.40) containing I mM-EGTA. To incorporate [3H]AA, 5 ml of a modified Tyrode-Hepes solution containing [3H]AA (0.5 ,uCi/ml) complexed to fatty acid-free bovine serum albumin (BSA) (100 mg/ml) [23] was added to 5 ml of platelet suspension in a modified Tyrode-Hepes buffer. After incubation for 120 min at 37°C in a shaking incubator bath, platelets were washed twice in a modified Tyrode-Hepes buffer containing I mM-EGTA. To obtain quin 2-loaded platelets, quin 2 acetoxymethyl ester was added during the last 30 [27] . The phases were separated by the addition of 0.6 ml of chloroform and 0.6 ml of 0.2 M-KCI/5 mM-EDTA [26] . After centrifugation, the lower organic phase was removed and evaporated under a stream of N2 gas. Neutral lipids were separated on silica-gel 60 plates impregnated with 0.4 M-boric acid in the solvent system chloroform/acetone (24: 1, v/v) [26] . Phospholipids were separated by two-dimensional t.l.c. on silica-gel 60 plates impregnated with 2.5 % (w/v) magnesium acetate, in chloroform/methanol/aq. 13.5 M-NH3 (65:35:6, by vol.) in the first dimension and chloroform/acetone/methanol/acetic acid/water (6:8:2:2: 1, by vol.) in the second [26] . Individual lipids were observed by exposure of the plates to '2 vapour and identified by co-migration with authentic standards. The areas corresponding to individual lipid fractions were scraped into vials and the radioactivity was determined in a liquid-scintillation counter [26] . Chemicals [5,6,8,9,11,12,14,15- 
Ca2T
he phospholipid source(s) of AA was examined by two-dimensional t.l.c. ( Table 2 ). Addition of 2 tM-A23187 to [3H]AA-prelabelled rat platelets induced loss of [3H]AA from phosphatidylcholine (PC) and phosphatidylethanolamine (PE). There was no decrease in 3H radioactivity in phosphatidylinositol (PI), but rather a small increase. Thrombin (2 units/ml) elicited a loss of [3H]AA from PC and PI, with a slight increase in 3H radioactivity of PE. Also the agent caused the formation of 1,2-diacylglycerol (DG) and phosphatidic acid (PA) after the breakdown of inositol phospholipids. (Table 5 ). The DG lipase inhibitor RHC 80267 [28] was without effect on AA release. In contrast, the phospholipase A2 inhibitors mepacrine [12, 26, 35] and ONO-RS-082 [20] effectively inhibited the release of AA, indicating phospholipid hydrolysis via phospholipase A2.
DISCUSSION
The release of AA from stimulated platelets is a ratelimiting step in the synthesis of biologically active eicosanoids [1] . Studies of AA metabolism in platelets indicate two major mechanisms for release of AA, one mediated by phospholipase A2 [2] and the other via phospholipase C followed by DG lipase [3] . The former pathway is considered to play a greater role [4] [5] [6] [7] [8] . It has generally been thought that the membrane-bound phospholipase A2 would be responsible for the generation of AA upon platelet activation. Membrane-bound phospholipase A2 has recently been purified from rat platelets [10] . Thus in the present study AA [9, 11, 36] . However, this unphysiologically high Ca2' requirement has been questioned for platelet activation [37] Table 4 . Ca2l-induced changes in 3H radioactivity distribution in rat platelet membrane phospholipids labelled with 13Hlglycerol
[3H]Glycerol-labelled rat platelet membranes (50 ,ug) were incubated with the indicated concentration of Ca2+ for 20 min at 37 'C. Other experimental conditions are described in [8, 24] . If (Table 2 ). This may be due to the transacylation of PC to plasmalogen-PE as previously reported [38, 39] . Although [36, 41] that phospholipase A2 preferentially hydrolysed PE and PC in rat platelets. Thus it is reasonable to consider that PC and PE serve as major AA sources.
On the other hand, Ca2+-induced AA liberation was not observed in human platelet membranes under the same experimental conditions (incubation for 20 min at 37°C in pH 7.4) as for rat platelet membranes (Fig. 1) . Although the release of AA from human platelet membranes has been demonstrated [42, 43] , it requires high concentrations of Ca2+ (10 mM), alkaline pH (8.5-10, optimal at 9.5) and longer incubation periods (more than 1 h). Thus it appears to be likely that Na+/H+ exchange, which leads to cytoplasmic alkalinization, promotes the activation of phospholipase A2 [19, 20] . In contrast, van den Bosch and co-workers [9] have demonstrated that human platelet phospholipase A2 is about 300-fold less active than that of rat platelet at both pH 7 and 9 in the presence of 10 mM-Ca2+. According to the recent observations [4] [5] [6] [7] [8] , AA liberation is thought to be mainly catalysed by phospholipase A2 in stimulated human platelets. Thus the human platelet enzyme may be activated by mechanism(s) additional to or independent of [Ca2+]i and pH. Recently, GTP-binding protein [22, 26, [44] [45] [46] and DG [47, 48] have been suggested to be implicated in phospholipase A2 activation. However, the precise mechanism of phospholipase A2 activation in human platelets still requires further investigation.
In summary, the rise in [Ca2+]i plays a primary role Vol. 259 in the activation of rat platelet phospholipase A2. In contrast, other regulatory factor(s) additional to or independent of Ca21 is required for human platelet phospholipase A2'
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